Login
Evidence Feed
About
Conferences
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
NCB-0846
i
Other names:
NCB 0846, NCB-0846
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Twitter
Trials
Company:
Carna Biosci, National Cancer Center
Drug class:
Wnt signalling pathway inhibitor, TNIK inhibitor
Related drugs:
‹
PRI724 (5)
WNT974 (2)
SM04690 (2)
BC2059 (2)
XAV-939 (1)
OMP-18R5 (1)
PRI724 (5)
WNT974 (2)
SM04690 (2)
BC2059 (2)
XAV-939 (1)
OMP-18R5 (1)
›
Associations
(1)
News
Twitter
Trials
Reset Filters
VERI cancer hierarchy
x
x
x
x
TNIK overexpression
Lung Non-Small Cell Squamous Cancer
TNIK overexpression
Lung Non-Small Cell Squamous Cancer
NCB-0846
Sensitive: D – Preclinical
AACR 2023 - 1 week (New D)
NCB-0846
Sensitive
:
D
AACR 2023 - 1wk
NCB-0846
Sensitive: D – Preclinical
AACR 2023 - 1 week
NCB-0846
Sensitive
:
D
AACR 2023 - 1 week - (New D)
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login